Rafael Zafra

Dr. Rafael Zafra


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2012 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
JLJames LaCourse
James LaCourse
SPSamirah Perally
Samirah Perally
Russell M MorphewRussell M Morphew
Russell M Morphew
Joe MoxonJoe Moxon
Joe Moxon
MPMark Prescott
Mark Prescott
PBPeter M Brophy
Peter M Brophy
Liver fluke infection of livestock causes economic losses of over US$ 3 billion worldwide per annum. The disease is increasing in livestock worldwide and is a re-emerging human disease. There are currently no commercial vaccines, and only one drug with significant efficacy against adult worms and juveniles. A liver fluke vaccine is deemed essential as short-lived chemotherapy, which is prone to resistance, is an unsustainable option in both developed and developing countries. Protein superfamilies have provided a number of leading liver fluke vaccine candidates. A new form of glutathione transferase (GST) family, Sigma class GST, closely related to a leading Schistosome vaccine candidate (Sm28), has previously been revealed by proteomics in the liver fluke but not functionally characterised. In this manuscript we show that a purified recombinant form of the F. hepatica Sigma class GST possesses prostaglandin synthase activity and influences activity of host immune cells. Immunocytochemistry and western blotting have shown the protein is present near the surface of the fluke and expressed in eggs and newly excysted juveniles, and present in the excretory/secretory fraction of adults. We have assessed the potential to use F. hepatica Sigma class GST as a vaccine in a goat-based vaccine trial. No significant reduction of worm burden was found but we show significant reduction in the pathology normally associated with liver fluke infection. We have shown that F. hepatica Sigma class GST has likely multi-functional roles in the host-parasite interaction from general detoxification and bile acid sequestration to PGD synthase activity. Combating neglected parasitic diseases is of paramount importance to improve the health of human populations and/or their domestic animals. Uncovering key roles in host-parasite interactions may support the vaccine potential portfolio of a parasite protein. Fasciola hepatica causes global disease in humans and their livestock but no commercial vaccines are available. Members of the Sigma class glutathione transferase (GST) family have long been highlighted as vaccine candidates towards parasitic flatworms. To this end, a Sigma class GST is currently undergoing phase II clinical trials to protect against infection from the schistosomes. In this study we characterise the protein from F. hepatica following four work pathways that 1) confirm its designation as a Sigma class GST using substrate profiling, 2) assess prostaglandin synthase activity and its effect on host immune cells, 3) localise the Sigma GST within adult fluke and between ontogenic stages and 4) measure its potential as a vaccine candidate. The work presented here shows F. hepatica Sigma class GST to have key host-parasite roles and we suggest, warrants further investigation for inclusion into vaccine formulations.

1 May 2013 in Journal of Comparative Pathology
Verified
Journal Article
Closed access
RZRafael Zafra
Rafael Zafra
APAlejandro Pérez-Écija
Alejandro Pérez-Écija
Leandro Buffoni PerazzoLeandro Buffoni Perazzo
Leandro Buffoni Perazzo
PMP. Moreno
P. Moreno
MBM.J. Bautista
M.J. Bautista
JPJosé Pérez
José Pérez


1 June 2008 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
RZRafael Zafra
Rafael Zafra
JJJ.R. Jaber
J.R. Jaber
APAlejandro Pérez-Écija
Alejandro Pérez-Écija
ABA. Barragán
A. Barragán
AMALVARO MARTINEZ-MORENO
ALVARO MARTINEZ-MORENO
JPJosé Pérez
José Pérez

1 April 2012 in Veterinary Parasitology
Verified
Journal Article
Closed access
Leandro Buffoni PerazzoLeandro Buffoni Perazzo
Leandro Buffoni Perazzo
FMF Javier Martínez-Moreno
F Javier Martínez-Moreno
RZRafael Zafra
Rafael Zafra
RMRicardo E. Mendes
Ricardo E. Mendes
APAlejandro Pérez-Écija
Alejandro Pérez-Écija
AMALVARO MARTINEZ-MORENO
ALVARO MARTINEZ-MORENO

5 January 2023 in Animals
Verified
Journal Article
Open access
PDF file
PHPablo Rodríguez Hernández
Pablo Rodríguez Hernández
CRCarolina Reyes-Palomo
Carolina Reyes-Palomo
SSSantos Sanz-Fernández
Santos Sanz-Fernández
PRPablo Jose Rufino-Moya
Pablo Jose Rufino-Moya
RZRafael Zafra
Rafael Zafra
CGCipriano Díaz Gaona
Cipriano Díaz Gaona
Internal parasites are one of the main causes of health threats in livestock production, especially in extensive livestock farming. Despite the environmental toxic effects (loss of dung beetles, biodiversity, and other issues) and resistance phenomenon derived from their prolonged use, anti-parasitic chemical pharmaceuticals are frequently used, even in organic farming. Such a situation within the context of climate change requires urgent exploration of alternative compounds to solve these problems and apparent conflicts between organic farming objectives regarding the environment, public health, and animal health. This review is focused on some plants (Artemisia spp., Cichorium intybus L., Ericaceae family, Hedysarum coronarium L., Lotus spp., Onobrychis viciifolia Scop.) that are well known for their antiparasitic effect, are voluntarily grazed and ingested, and can be spontaneously found or cultivated in southern Europe and other regions with a Mediterranean climate. The differences found between effectiveness, parasite species affected, in vitro/in vivo experiments, and active compounds are explored. A total of 87 papers where antiparasitic activity of those plants have been studied are included in this review; 75% studied the effect on ruminant parasites, where gastrointestinal nematodes were the parasite group most studied (70%), and these included natural (31%) and experimental (37%) infections.